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In mammals, the promoters of expressed genes are
generally unmethylated, whereas those of genes that
are not expressed are methylated. Two recent papers
help to explain the mechanism by which methylation
modulates gene expression.
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Mammalian DNA shows a striking epigenetic
modification — the methylation of cytosines, forming 5-
methylcytosine, which occurs exclusively where a cytosine
occurs immediately 5′ to a guanosine, forming what is
commonly referred to as a CpG dinucleotide. Approx-
imately 60–90% of the CpGs in the genome of an adult
mammal are methylated in this way, a pattern which is set
up during embryogenesis. In the blastula, most of the
DNA is unmethylated; after implantation, a wave of de
novo methylation modifies most of the genome except for
the so-called ‘CpG islands’ — regions with very high
densities of CpGs — which are associated with the
essential, ‘housekeeping’ genes and which remain
unmodified. Tissue-specific genes undergo demethylation
only in the tissues in which they are expressed, creating a
bimodal pattern of methylation which is maintained in the
adult. Thus, a correlation is observed between hypo-
methylation of the promoter region and transcriptional
activity [1].
DNA methylation is necessary for proper embryonic
development, as mice lacking any functional DNA
methyltransferase gene fail to develop properly and die in
midgestation [2]. It has been suggested that methylation is
a novel repression mechanism developed in more complex
organisms to reduce ‘transcriptional noise’ [3] — the
inappropriate transcription of a gene in cells where it is
meant to be silent. One would expect such stochastic mis-
firing of a gene to be more of a problem the greater the
number of genes, and this might be particularly important if
the misexpression of a gene during crucial points of devel-
opment is lethal. One can imagine that disrupting a global
repression mechanism would have deleterious effects on
the developing embryo. 
Several lines of evidence indicate that the relationship
between methylation and gene expression is not just
correlative. The methylation of genes in vitro prevents
their subsequent expression in transfected fibroblasts [4].
In addition, the treatment of cells with 5-azacytidine, an
inducer of demethylation, leads to the activation of several
repressed endogenous genes [5]. These experiments and
others have shown that methylation actually causes the
repression of gene expression.
There appear to be three possible ways by which
methylation can affect gene expression. One involves the
methylated CpG residues interfering directly with the
binding of specific transcription factors to DNA. Several
transcription factors — AP-2, c-Myc/Myn, E2F and NFkB
— bind to DNA sequences that include CpGs and have
been shown to be sensitive to methylation at these sites.
Some transcription factors, however, are not sensitive to
methylation — examples are Sp1, CTF and YY1 [6]. Most
of the factors that have been shown to be methylation-
sensitive are ubiquitous. Methylation does not appear to
interfere with the binding of gene-specific transcription
factors, but rather to interfere with the binding of
ubiquitous factors in cells where the gene is not expressed
[7]. Methylation therefore works as a global mechanism of
repression.
A second possibility is that the direct binding of specific
factors to methylated DNA mediates repression. Two
such factors, MeCP1 and MeCP2, have been identified
and shown to bind to methylated CpG in any sequence
context. MeCP1 binds to DNA containing multiple
symmetrically methylated CpGs [8]. MeCP2 is more
abundant than MeCP1 in the cell and is able to bind to
DNA that is asymmetrically methylated, with just a single
methyl-CpG. In addition, the distribution of MeCP2 on
the chromosome parallels that of methyl-CpG [9].
Experiments on mice with a disrupted MeCP2 gene have
shown that MeCP2, like DNA methyltransferase, is
dispensable in stem cells, but essential for embryonic
development [10].
A new study by Nan et al. [11] has identified a repressor
domain in the MeCP2 protein, which may explain its
mode of action. It has previously been shown that the
protein contains a methyl-CpG-binding domain of 80
amino acids which is essential for chromosomal localiza-
tion [12,13]. Now, they have shown that the carboxy-
terminal half of the protein contains a basic repressor
domain which can inhibit transcription from a promoter at
a distance, consistent with the view that MeCP2 interacts
with the transcriptional machinery or the initiation
complex, rather than interfering with the binding of
specific transcription factors. This suggests a mechanism
by which methylated CpGs target the binding of proteins
that contain repression domains and thereby inhibit
expression. Many DNA-binding factors have difficulty
accessing DNA when it is packaged in chromatin. In order
for MeCP2 to repress expression from methylated genes,
it has to be able to bind the DNA in the form that it is
found in vivo, as chromatin. Indeed, MeCP2 has been
shown to access sites on chromatin directly, suggesting
that the binding of MeCP2 may stabilize and/or maintain
the inactive chromatin.
A third strategy by which methylation may cause
repression is by altering chromatin structure (Fig. 1). It has
been shown that methylated DNA affects the positioning
of nucleosomes and influences the sensitivity of the DNA
to DNase I [14]. Further experiments using microinjec-
tion of methylated and nonmethylated templates into
nuclei have shown that methylation inhibits expression
only after chromatin is assembled [15]. These results
support the view that methylation induces a change in
conformation of chromatin to an inactive state. Kass et al.
[16] have now elucidated further details of this
mechanism. They have found that, after injection into
Xenopus oocyte nuclei, both methy-
lated and unmethylated templates are
initially equally active. After longer
incubation times, however, the
methylated DNA is converted to an
inactive form characterized by the loss
of DNaseI hypersensitivity and of
engaged RNA polymerase, and by the
assembly of the inactivated promoter
into a nucleosomal array. These
results are consistent with the idea
that the methylated DNA is assem-
bled into a chromatin structure that
inhibits transcription. 
In vitro studies of chromatin formation
have identified two levels of repres-
sion of nonmethylated templates.
The assembly of nucleosome cores
alone is able to bring about repres-
sion of basal transcription, but at
lower nucleosome densities, such as
those found in mammalian nuclei,
histone H1 — the ‘linker’ histone
between the cores — is crucial for
complete repression. The addition of
a strong activator, such as
GAL4–VP16, can only counteract the
repression caused by the addition of
histone H1 [17]. Kass et al. [16] have
found that, in contrast to unmethy-
lated DNA, GAL4–VP16 cannot
counteract the effect of chromatin
once it has assumed the inactive state induced by DNA
methylation. In this way, methylation not only stabilizes
the inactive state but also prevents activation by
blocking transcription factors.
Once the repressed state is established, the next question
is how to activate an inactive gene. During development,
stage-specific genes need to be activated at specific
times. As these genes are presumably methylated and in
an inactive chromatin conformation, how is activation
accomplished? In light of the findings of Nan et al. [11]
and Kass et al. [16], it appears that two events must occur
before these genes may be activated: firstly, the
methylation must be removed; and secondly, changes in
chromatin must occur. It has already been shown that
demethylation is necessary for gene expression [18]: now,
the molecular mechanisms are becoming clear.
Demethylation will cause the removal of specific factors
that bind methylated DNA, such as MeCP2, and thus
allow the destabilization of the chromatin. Once the chro-
matin is in a more accessible conformation, the binding of
specific complexes such as SWI/SNF can relieve
nucleosomal inhibition. 
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Figure 1
A model of how methylation may cause
repression. The top shows nonmethylated,
active chromatin with an activator (yellow) and
transcription complex (green) engaged.
Methylation modifies the chromatin structure
to induce an inactive state. This inactive
chromatin is resistant to activators and does
not support transcription. MeCP2 (red) can
bind to the methylated DNA directly, and has
a repressor domain that can interfere with the
transcriptional machinery at a distance.
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In conclusion, the methylation of CpG residues in the
genome maintains and stabilizes the inactive state of chro-
matin. When chromatin is in this conformation, no expres-
sion can occur. In order to activate a gene that is in this
state, the DNA has first to be demethylated, allowing the
reversal of the inactive state of the chromatin and tran-
scription to occur.
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